(Q43085392)

English

Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae

scientific article published on 9 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae (English)

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Klebsiella pneumoniae

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Giancarlo Ceccarelli

1

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

2

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Maria Lina Mezzatesta

4

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Stefania Stefani

6

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

7

object named as

Mario Venditti

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

author name string

Alessandra Giordano

3

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Carla Caio

5

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

language of work or name

0 references

publication date

9 April 2013

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

57

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

6

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

2900-2901

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716145

25 May 2018

High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716145

25 May 2018

Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716145

25 May 2018

Surveillance and management of multidrug-resistant microorganisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716145

25 May 2018

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716145

25 May 2018

Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716145

25 May 2018

Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716145

25 May 2018

Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716145

15 August 2018

Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716145

15 August 2018

Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716145

1 December 2018

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23571536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.00188-13

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43085392&oldid=1980506090"